Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
All articles by Bradley van Paridon
Which prognostic models or indicators effectively predict critical care outcomes among patients hospitalized for COVID-19 pneumonia?
Researchers evaluated inflammatory biomarkers among patients with HIV who switched from a 3-drug antiretroviral therapy regimen to a 2-drug regimen of dolutegravir plus lamivudine.
Researchers evaluated different durations of fexinidazole treatment in patients with Chagas disease.
Researchers assessed the safety and effectiveness of twice-daily dolutegravir dosing plus rifampicin in children with HIV-associated tuberculosis infection.
Should clofazimine remain a “second-choice agent” for treating patients with multidrug-resistant tuberculosis? A meta-analysis reviews the current evidence.
Researchers assessed the duration of protection conferred by vaccination against yellow fever among healthy adults and children and those with immunocompromised conditions.
Researchers assessed the effect of triple therapy with ribavirin plus sofosbuvir and daclatasvir on sustained virologic response achievement in patients with hepatitis C complicated by cirrhosis.
Researchers compared patient satisfaction with telemedicine visits conducted via phone vs video.
Researchers evaluated the risk for stroke 30 days following herpes zoster infection and the effect of prior varicella zoster virus vaccination on stroke risk.